TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 102 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,000 | – | 11 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 94,031 | $10,164,000 | 2.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 20,530 | $2,219,000 | 1.88% |
| Strategic Global Advisors, LLC | 72,308 | $7,816,000 | 1.64% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $3,074,000 | 0.95% |
| Freestone Capital Holdings, LLC | 129,757 | $14,025,000 | 0.83% |
| Hudson Capital Management LLC | 12,394 | $1,339,667,000 | 0.82% |
| FORT, L.P. | 19,158 | $2,071,000 | 0.42% |
| MENTA CAPITAL LLC | 6,880 | $744,000 | 0.32% |
| Empirical Finance, LLC | 9,511 | $1,028,000 | 0.26% |
| ALGERT GLOBAL LLC | 4,071 | $440,000 | 0.25% |